AnodyneWiki

Mifepristone

Mifepristone
Mifepristone
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass429.60 g/mol [1]
AppearanceYellow powder [1]
Melting point191-196 °C [1]
SolubilityPoorly soluble [1]
Predicted LogP3.8 [1]
Structural Identifiers
[]
Molecular formulaC29H35NO2
IUPAC name(8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
SMILESCC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O
InChIInChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1
InChIKeyVKHAHZOOUSRJNA-GCNJZUOMSA-N
CAS number84371-65-3
UNII320T6RNW1F
PubChem CID55245
Pharmacokinetics[]
MetabolismLiver
ExcretionFeces: 83%, urine: 9%
Routes of administrationBy mouth

Mifepristone (also known as Mifegyne, Mifeprex, Ru-486, Korlym, Ru 486, Mifepristona, Ru 38486, Mifepristonum, Ru-38486 or Zk 98296) is a substance of the aniline and steroid class.

Chemistry

 []

Mifepristone is a single defined stereoisomer.

Mifepristone matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

The anti-progestational activity of mifepristone results from competitive interaction with progesterone at progesterone-receptor sites. Based on studies with various oral doses in several animal species (mouse, rat, rabbit and monkey), the compound inhibits the activity of endogenous or exogenous progesterone. The termination of pregnancy results. In the treatment of Cushing's syndrome, Mifepristone blocks the binding of cortisol to its receptor. It does not decrease cortisol production but reduces the effects of excess cortisol, such as high blood sugar levels. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

induction / metabolism / inhibition83 (3 contraindicated)
inhibition35 (1 contraindicated)
shared target1

Medical side effects []

87 side effects listed on drug labels in (mifepristone).

  • Asthenia
  • Fatigue
  • Headache
  • Endometrial hypertrophy
  • Endometrial thickening
  • Blood potassium decreased
  • Arthralgia
  • Musculoskeletal discomfort
  • Myalgia
  • Vomiting
  • Oedema peripheral
  • Hypertension
  • Dizziness
  • Decreased appetite
  • Anorexia
  • Dry mouth
  • Thyroid function test abnormal
  • Back pain
  • Dyspnoea
  • Pain
  • Sinusitis
  • Diarrhoea
  • Nasopharyngitis
  • Pain in extremity
  • Anxiety
  • Constipation
  • Somnolence
  • Infection
  • Pruritus
  • Hypotension
  • Abdominal pain
  • Gastrointestinal pain
  • Ectopic ACTH syndrome
  • Adrenal insufficiency
  • Angioedema
  • Mental disorder
  • Breast disorder
  • Connective tissue disorder
  • Dermatitis exfoliative
  • Oedema
  • Pitting edema
  • Endometritis
  • Toxic epidermal necrolysis
  • Erythema nodosum
  • Dermatitis
  • Rash
  • Body temperature increased
  • Flank pain
  • Gastrooesophageal reflux disease
  • Gastrointestinal disorder
  • Haemorrhage
  • Haemoglobin
  • Hypersensitivity
  • Hypoglycaemia
  • Hypokalaemia
  • Mediastinal disorder
  • Metrorrhagia
  • Multiparous
  • Muscle spasms
  • Nausea
  • Nervous system disorder
  • Thirst
  • Urticaria
  • Uterine contractions during pregnancy
  • Uterine rupture
  • Angiopathy
  • Chills
  • Muscular weakness
  • Malnutrition
  • Skin disorder
  • Pituitary-dependent Cushing's syndrome
  • Malaise
  • Discomfort
  • Feeling abnormal
  • Ill-defined disorder
  • Pelvic inflammatory disease
  • Rash maculo-papular
  • Endometrial cancer
  • Musculoskeletal chest pain
  • Menopausal symptoms
  • Hot flush
  • Toxic shock syndrome
  • Infestation
  • Blood triglycerides increased
  • Insomnia
  • Adrenal gland cancer
  • Vaginal haemorrhage

Indications

  • Cushing's syndrome
  • Dead foetus
  • Foetal death
  • Glucose tolerance impaired
  • Hyperglycaemia
  • Type 2 diabetes mellitus

 []

  • Australia: Mifepristone is a Schedule 4.
  • Canada: Mifepristone is Prescription only.[3][4]
  • United States: Mifepristone is Prescription only.[5]
  • Other: Mifepristone is a Rx-only.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 55245, Mifepristone. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/55245
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Mifepristone. UNII: 320T6RNW1F. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/320T6RNW1F
  3. Mifegymiso Product information. Health Canada. 10 January 2017. https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92881
  4. Mifiso Product information. Health Canada. 16 December 2022. https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102254
  5. Mifeprex- mifepristone tablet. DailyMed. 12 March 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=61626f72-7469-6f6e-4953-6d7572646572

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 14:02:31
drugspromissing (no DrugsPRO reagent data)2026-11-20 14:02:27
erowidmissing (no Erowid substance of that name)2026-11-20 14:02:27
gsrsok2026-11-20 14:02:27
hmdbmissing (hmdb.ca refused automated access to HMDB0014972)2026-11-20 14:02:27
keggok2026-11-20 14:02:29
pubchemok2026-11-20 14:02:27
redditmissing (no r/tripreports posts mention it)2026-11-20 14:02:27
siderok2026-11-20 14:02:27
structureok2026-11-20 14:02:27
wikipediaok2026-11-20 14:02:27